B09 CARTITUDE-2 COHORT B 18-MONTH FOLLOW-UP: CILTACABTAGENE AUTOLEUCEL (CILTA-CEL), A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH MULTIPLE MYELOMA (MM) AND EARLY RELAPSE AFTER INITIAL THERAPY

• S. Zweegman,
• M. Agha,
• A.D. Cohen,
• Y.C. Cohen,
• S. Anguille,
• T. Kerre,
• W. Roeloffzen,
• D. Madduri,
• J.M. Schecter,
• K.C. De Braganca,
• C.C. Jackson,
• H. Varsos,
• P. Mistry,
• T. Roccia,
• X. Xu,
• K. Li,
• E. Zudaire,
• C. Corsale,
• M. Akram,
• D. Geng,
• L. Pacaud,
• P. Sonneveld,
• N. van de Donk

Affiliations

S. Zweegman

1 Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands

M. Agha

2 UPMC Hillman Cancer Center, Pittsburgh, PA, USA

A.D. Cohen

3 Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Y.C. Cohen

4 Tel-Aviv Sourasky (Ichilov) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

S. Anguille

5 Vaccine and Infectious Disease Institute, University of Antwerp, Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium

T. Kerre

6 Ghent University Hospital, Ghent, Belgium

W. Roeloffzen

7 University Medical Center Groningen, Groningen, the Netherlands

D. Madduri

8 Mount Sinai Medical Center, New York, NY, USA

J.M. Schecter

9 Janssen Research & Development, Raritan, NJ, USA

K.C. De Braganca

9 Janssen Research & Development, Raritan, NJ, USA

C.C. Jackson

9 Janssen Research & Development, Raritan, NJ, USA

H. Varsos

9 Janssen Research & Development, Raritan, NJ, USA

P. Mistry

10 Janssen Research & Development, High Wycombe, United Kingdom

T. Roccia

11 Janssen Global Services, Raritan, NJ, USA

X. Xu

9 Janssen Research & Development, Raritan, NJ, USA

K. Li

12 Janssen Research & Development, Spring House, PA, USA

E. Zudaire

12 Janssen Research & Development, Spring House, PA, USA

C. Corsale

9 Janssen Research & Development, Raritan, NJ, USA

M. Akram

13 Legend Biotech USA, Piscataway, NJ, USA

D. Geng

13 Legend Biotech USA, Piscataway, NJ, USA

L. Pacaud

13 Legend Biotech USA, Piscataway, NJ, USA

P. Sonneveld

14 Erasmus MC Cancer Institute, Rotterdam, the Netherlands

N. van de Donk

1 Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands